Department of Clinical Genetics, Lund University Hospital, Lund, Sweden.
Obesity (Silver Spring). 2010 Mar;18(3):580-7. doi: 10.1038/oby.2009.298. Epub 2009 Sep 17.
Small supernumerary marker chromosomes (sSMCs) derived from the near-centromeric area of chromosome 2 are very rare. In addition, duplications of the 2p11.2-->q11.2 region have displayed considerable variability between patients harboring and lacking clinical findings. Moreover, constitutional duplication of the 19q12-->q13.2 region has previously only been described in two cases and was associated with delay of developmental milestones, corpus callosum anomalies, and obesity. Herein, we present a genotype-phenotype correlation in a patient harboring two sSMCs derived from chromosomes 2 and 14 or 22, respectively. The DNA was studied using G-banding, fluorescence in situ hybridization techniques, and array-based comparative genomic hybridization. A 48,XX,+der(2)del(2)(p11)del(2)(q11.2),+der(14)t(14;19)(q11;q12)del(19)(q13.31) or 48,XX,+der(2)del(2)(p11)del(2)(q11.2),+der(22)t(22;19)(q11;q12)del(19)(q13.31) was detected in the patient. The sSMC 14;19 or 22;19, with its centromere originating from either chromosome 14 or 22, encompassed a 13.56 megabase (Mb) 19q derived region, harboring 263 genes, and the sSMC 2 a 2.71 Mb region including 29 genes. The patient had symptoms including a ventral septal defect, bilateral grade IV urinary reflux, corpus callosum agenesis, microphthalmia, and obesity. The 19q segment contained the genes AKT2, CEACAM1, CEBPA, LIPE, and TGFB1 which are involved in adipose tissue homeostasis and insulin resistance, and could potentially contribute to the obese phenotype observed. Array-based genetic characterization and long-term clinical evaluation with attention toward weight gain in patients with chromosome 19q duplications might in the future lead to the description of a obesity-associated genetic syndrome, something that could have implications in management and treatment of patients carrying a dup(19)(q12q13.2). Whether the der(2)(p11q11.2) contributes to the phenotype remains inconclusive.
小型额外标记染色体(sSMC)来源于染色体 2 的近着丝粒区域,非常罕见。此外,2p11.2-->q11.2 区域的重复在携带和不携带临床发现的患者之间表现出相当大的可变性。此外,19q12-->q13.2 区域的结构重复以前仅在两例中描述过,并与发育里程碑延迟、胼胝体异常和肥胖有关。在此,我们介绍了一名患者的基因型-表型相关性,该患者携带分别来自染色体 2 和 14 或 22 的两个 sSMC。使用 G 带、荧光原位杂交技术和基于阵列的比较基因组杂交技术对 DNA 进行了研究。在患者中检测到 48,XX,+der(2)del(2)(p11)del(2)(q11.2),+der(14)t(14;19)(q11;q12)del(19)(q13.31) 或 48,XX,+der(2)del(2)(p11)del(2)(q11.2),+der(22)t(22;19)(q11;q12)del(19)(q13.31)。sSMC 14;19 或 22;19,其着丝粒源自染色体 14 或 22,包含一个源自 19q 的 13.56 兆碱基(Mb)区域,包含 263 个基因,sSMC 2 包含一个 2.71 Mb 区域,包含 29 个基因。患者有症状,包括腹侧隔缺损、双侧 IV 级尿反流、胼胝体发育不全、小眼和肥胖。19q 片段包含 AKT2、CEACAM1、CEBPA、LIPE 和 TGFB1 等基因,这些基因参与脂肪组织稳态和胰岛素抵抗,可能有助于观察到的肥胖表型。基于阵列的遗传特征和长期临床评估,以及对 19q 重复患者体重增加的关注,未来可能会描述一种与肥胖相关的遗传综合征,这可能对携带 dup(19)(q12q13.2)的患者的管理和治疗产生影响。der(2)(p11q11.2) 是否有助于表型尚不确定。